Lotus Health Group Co.

Lotus Health Group Co. has seen notable stock performance, with significant gains over the past week and month, and a substantial year-to-date increase. However, the company has struggled over the past year, contrasting with broader market trends. It holds a strong market capitalization within the FMCG sector.

Lotus Health Group Co. has experienced notable stock performance, with significant gains over various time frames. Despite a challenging year, the company maintains a strong market capitalization and key financial metrics that indicate a premium valuation, positioning it well within the FMCG sector.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and achieving an intraday high. Over the past week, the stock has increased substantially, with impressive annual returns that outpace the broader market. The company maintains a large market capitalization and a strong return on equity.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and achieving an intraday high. Over the past week, the company has shown substantial growth, with impressive year-to-date and three-year performance figures, despite underperforming relative to the market over the past year. Financial metrics indicate strong operational efficiency.

Lotus Health Group Co. has experienced notable stock performance, achieving an intraday high while the broader market declined. The company has shown strong year-to-date growth and impressive long-term gains, although it has faced challenges over the past year. Its financial metrics indicate a premium valuation within the FMCG sector.

Lotus Health Group Co. has seen a significant stock increase today, contrasting with a decline in the broader market. Over the past year, the company has outperformed the China Shanghai Composite, with notable gains in the FMCG sector, despite recent short-term challenges. Its financial metrics indicate strong profitability and a premium valuation.

Lotus Health Group Co. faced a decline today, with its stock hitting an intraday low amid a slight drop in the broader market. Despite a year-to-date increase, the company has struggled over the past year, raising concerns about its market position within the FMCG sector. Key financial metrics indicate a high valuation.

Lotus Health Group Co. saw a notable decline in its stock today, contrasting with the broader market's performance. Despite a year-to-date increase, the company has struggled over the past year. Key financial metrics indicate a high valuation and operational efficiency, with a market capitalization of CNY 18,449 million.

Lotus Health Group Co. faced a significant stock price decline on May 28, 2026, reaching an intraday low. Despite this, the company has shown strong year-to-date performance, outperforming the China Shanghai Composite. Key financial metrics indicate a high valuation, with profits increasing despite recent challenges.

Lotus Health Group Co. has seen notable stock activity, rising significantly today and over the past week and month. Despite impressive year-to-date gains, the company faces challenges with a relatively high valuation and a less favorable annual performance compared to the broader market. The FMCG sector remains volatile.

Lotus Health Group Co. has seen a notable increase in its stock price, outperforming the broader market significantly. Over the past week and month, the stock has shown impressive gains, while year-to-date returns highlight its strong performance. However, the company faces challenges with its valuation metrics and recent annual performance.

Lotus Health Group Co. saw its stock price decline today amid a broader market downturn, despite a strong performance over the past month. The company has faced challenges over the past year, with negative returns, while maintaining a notable market capitalization and key financial metrics indicating a high valuation.

Lotus Health Group Co. has recently experienced a change in evaluation, reflecting its evolving market position. The company's financial metrics show flat quarterly performance, with a notable increase in interest but a declining inventory turnover ratio. Its stock performance has lagged behind the broader market over the past year.

Lotus Health Group Co. has recently experienced a change in evaluation, indicating a shift in its market position. The company reported flat financial performance for the quarter ending September 2025, with a significant increase in profits over the past year, yet its stock has underperformed compared to the broader market.

Lotus Health Group Co. saw a notable increase in stock performance on March 24, 2026, reaching an intraday high. The company has demonstrated resilience with positive metrics over various time frames, including a year-to-date performance of 13.21%. It maintains a strong return on equity and operational efficiency.

Lotus Health Group Co. faced a significant stock price decline today, reaching an intraday low. Over the past year, the company has underperformed compared to the Shanghai Composite, despite a positive year-to-date performance. Key financial metrics reveal high valuation and potential inefficiencies in inventory management.

Lotus Health Group Co. saw a notable stock price increase on March 19, 2026, reaching an intraday high amid a declining broader market. The company has demonstrated strong performance metrics over various time frames, although it faces challenges related to valuation and recent market underperformance.

Lotus Health Group Co. faced a notable decline in its stock today, contrasting with the broader market's performance. Over the past week and month, the company has seen decreases, while its annual performance lags behind the market. Despite a significant profit increase, its long-term growth remains impressive.

Lotus Health Group Co. has experienced notable stock activity, rising significantly today while the broader market declined. Year-to-date, the stock has outperformed the China Shanghai Composite, despite a one-year decline. The company, in the FMCG sector, has a market capitalization of CNY 11,401 million and strong profit growth.